In a study from Ho et al., they found no differences between stage I/II and III/IV endometriosis and controls in any of the identified activated phenotypes, including HLA-DR+, CD25+, CD28+, and CD69+ CD8 T cells (43). This evidence concerns the gene CD69 and endometriosis.